Five pre-radiotherapy clinical characteristics (the random GH value, nadir GH value, GH inhibition ratio after OGTT, tumor volume, and Knosp grade) were significantly associated with the radiotherapeutic response in patients with acromegaly (P = 0.000–0.040). The gene discussed is GH1; the disease is neoplasm.